AR092719A1 - Metodo y composicion para el tratamiento de ectoparasitos - Google Patents

Metodo y composicion para el tratamiento de ectoparasitos

Info

Publication number
AR092719A1
AR092719A1 ARP130103492A ARP130103492A AR092719A1 AR 092719 A1 AR092719 A1 AR 092719A1 AR P130103492 A ARP130103492 A AR P130103492A AR P130103492 A ARP130103492 A AR P130103492A AR 092719 A1 AR092719 A1 AR 092719A1
Authority
AR
Argentina
Prior art keywords
animal
spinosyne
treatment
composition
ectoparasites
Prior art date
Application number
ARP130103492A
Other languages
English (en)
Inventor
Al Alawi Fadil
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of AR092719A1 publication Critical patent/AR092719A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Método de tratamiento de un animal infestado con piojos mordedores caracterizado por el paso de administrar internamente al animal una cantidad farmacéuticamente eficaz de -al menos- una espinosina, de modo tal que la espinosina esté presente sistémicamente dentro del animal. Reivindicación 11: Una composición para la administración interna a un animal, que incluye una espinosina en el orden de 0,1% a 65% p/v. Reivindicación 12: Un régimen de dosificación para el tratamiento de piojos mordedores en un animal, caracterizado por el paso de administrar una espinosina internamente con una dosis igual a -o menor que- 40 miligramos por kilogramo del animal.
ARP130103492A 2012-09-28 2013-09-27 Metodo y composicion para el tratamiento de ectoparasitos AR092719A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ60272312 2012-09-28

Publications (1)

Publication Number Publication Date
AR092719A1 true AR092719A1 (es) 2015-04-29

Family

ID=50388697

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103492A AR092719A1 (es) 2012-09-28 2013-09-27 Metodo y composicion para el tratamiento de ectoparasitos

Country Status (5)

Country Link
AR (1) AR092719A1 (es)
AU (2) AU2012233000B2 (es)
UY (1) UY35059A (es)
WO (1) WO2014051440A1 (es)
ZA (1) ZA201502205B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2557986C1 (ru) * 2014-07-31 2015-07-27 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт ветеринарной энтомологии и арахнологии" (ФГБНУ ВНИИВЭА) Способ защиты крупного рогатого скота от иксодовых клещей
AU2020404003A1 (en) 2019-12-16 2022-05-26 Intervet International B.V. Parasite control in ruminants
EP4075981A1 (en) 2019-12-16 2022-10-26 Intervet International B.V. Composition for lice control

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591606A (en) * 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
JP4258575B2 (ja) * 1993-03-12 2009-04-30 ダウ・アグロサイエンス・エル・エル・シー 新規a83543化合物及びそれらの製造法

Also Published As

Publication number Publication date
AU2012233000A1 (en) 2014-04-17
AU2016202546A1 (en) 2016-05-19
ZA201502205B (en) 2017-11-29
UY35059A (es) 2014-03-31
AU2012233000B2 (en) 2016-01-21
WO2014051440A1 (en) 2014-04-03

Similar Documents

Publication Publication Date Title
BR112012023021A2 (pt) compostos de indazol e seus usos
NZ604029A (en) Methods of treating bladder cancer
BR112015023922A2 (pt) composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
CR11724A (es) Agente para tratar enfermedades
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
CO6251212A2 (es) Tratamiento terapeutico de sindrome metabolico diabetes tipo 2 obesidad o prediabetes
CR11723A (es) Agente para tratar enfermedad
BR112014015482A2 (pt) compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
BR112018067906A2 (pt) métodos de tratamento de depressão usando antagonistas do receptor de orexina-2
FR3034993B1 (fr) Conditionnement unitaire, compositions et schemas therapeutiques pour l'administration de stimulateurs des voies de pro-resolution sur des surfaces keratiniques
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
RU2011125640A (ru) Глазные капли с дифлупреднатом для лечения отека желтого пятна
AR092719A1 (es) Metodo y composicion para el tratamiento de ectoparasitos
MD20140004A2 (en) Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
AR093908A1 (es) Fusion de la hormona de crecimiento humana y albumina, formulacion y usos de la misma
AR088204A1 (es) Medicamentos para el tratamiento de la rinitis alergica que comprenden un antagonista de pgd2 y un antagonista de histamina
HRP20230300T1 (hr) Kombinacije imetelstata i venetoklaksa za liječenje akutne mijeloidne leukemije
HRP20171532T1 (hr) Apoekvorin za smanjenje neuronalne ozljede uvjetovane ishemijom
AR098832A1 (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington
CO2020001887A2 (es) Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático
EA201591603A1 (ru) Новые терапевтические комбинации миртазапина для применения при болевых расстройствах
TN2016000179A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor.
AR105087A1 (es) Métodos para el tratamiento de mujeres con trastorno de deseo sexual hipoactivo (hsdd) con el tratamiento de combinación bupropión y trazodona
EA201592261A1 (ru) Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой

Legal Events

Date Code Title Description
FB Suspension of granting procedure